nodes	percent_of_prediction	percent_of_DWPC	metapath
Milnacipran—Urinary tract infection—Rosuvastatin—atherosclerosis	0.00607	0.00607	CcSEcCtD
Milnacipran—Haematuria—Rosuvastatin—atherosclerosis	0.00595	0.00595	CcSEcCtD
Milnacipran—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.00591	0.00591	CcSEcCtD
Milnacipran—Disturbance in sexual arousal—Niacin—atherosclerosis	0.00585	0.00585	CcSEcCtD
Milnacipran—Migraine—Niacin—atherosclerosis	0.00581	0.00581	CcSEcCtD
Milnacipran—Urinary retention—Niacin—atherosclerosis	0.00561	0.00561	CcSEcCtD
Milnacipran—Hepatitis—Rosuvastatin—atherosclerosis	0.00561	0.00561	CcSEcCtD
Milnacipran—Erectile dysfunction—Lovastatin—atherosclerosis	0.00547	0.00547	CcSEcCtD
Milnacipran—Liver function test abnormal—Niacin—atherosclerosis	0.00545	0.00545	CcSEcCtD
Milnacipran—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.00541	0.00541	CcSEcCtD
Milnacipran—Dry skin—Niacin—atherosclerosis	0.00541	0.00541	CcSEcCtD
Milnacipran—Erectile dysfunction—Ezetimibe—atherosclerosis	0.00536	0.00536	CcSEcCtD
Milnacipran—Liver function test abnormal—Pravastatin—atherosclerosis	0.00536	0.00536	CcSEcCtD
Milnacipran—Dry skin—Pravastatin—atherosclerosis	0.00532	0.00532	CcSEcCtD
Milnacipran—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.00525	0.00525	CcSEcCtD
Milnacipran—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.00516	0.00516	CcSEcCtD
Milnacipran—Urinary tract infection—Lovastatin—atherosclerosis	0.00514	0.00514	CcSEcCtD
Milnacipran—Abdominal distension—Niacin—atherosclerosis	0.00513	0.00513	CcSEcCtD
Milnacipran—Erectile dysfunction—Simvastatin—atherosclerosis	0.00511	0.00511	CcSEcCtD
Milnacipran—Abdominal distension—Pravastatin—atherosclerosis	0.00505	0.00505	CcSEcCtD
Milnacipran—Angina pectoris—Niacin—atherosclerosis	0.00497	0.00497	CcSEcCtD
Milnacipran—Mental disorder—Rosuvastatin—atherosclerosis	0.00491	0.00491	CcSEcCtD
Milnacipran—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.00491	0.00491	CcSEcCtD
Milnacipran—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.00491	0.00491	CcSEcCtD
Milnacipran—Angina pectoris—Pravastatin—atherosclerosis	0.00489	0.00489	CcSEcCtD
Milnacipran—Flatulence—Rosuvastatin—atherosclerosis	0.00481	0.00481	CcSEcCtD
Milnacipran—Hepatitis—Lovastatin—atherosclerosis	0.00475	0.00475	CcSEcCtD
Milnacipran—Erectile dysfunction—Niacin—atherosclerosis	0.00469	0.00469	CcSEcCtD
Milnacipran—Dysuria—Pravastatin—atherosclerosis	0.00469	0.00469	CcSEcCtD
Milnacipran—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00466	0.00466	CcSEcCtD
Milnacipran—Hepatitis—Ezetimibe—atherosclerosis	0.00466	0.00466	CcSEcCtD
Milnacipran—Erectile dysfunction—Pravastatin—atherosclerosis	0.00462	0.00462	CcSEcCtD
Milnacipran—Oedema peripheral—Ezetimibe—atherosclerosis	0.00459	0.00459	CcSEcCtD
Milnacipran—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00458	0.00458	CcSEcCtD
Milnacipran—Weight decreased—Pravastatin—atherosclerosis	0.00454	0.00454	CcSEcCtD
Milnacipran—Erythema multiforme—Lovastatin—atherosclerosis	0.00449	0.00449	CcSEcCtD
Milnacipran—Hepatitis—Simvastatin—atherosclerosis	0.00444	0.00444	CcSEcCtD
Milnacipran—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.00444	0.00444	CcSEcCtD
Milnacipran—Flushing—Lovastatin—atherosclerosis	0.00441	0.00441	CcSEcCtD
Milnacipran—Erythema multiforme—Ezetimibe—atherosclerosis	0.00441	0.00441	CcSEcCtD
Milnacipran—Urinary tract infection—Pravastatin—atherosclerosis	0.00435	0.00435	CcSEcCtD
Milnacipran—Flushing—Ezetimibe—atherosclerosis	0.00432	0.00432	CcSEcCtD
Milnacipran—Chills—Lovastatin—atherosclerosis	0.00426	0.00426	CcSEcCtD
Milnacipran—Angiopathy—Ezetimibe—atherosclerosis	0.00423	0.00423	CcSEcCtD
Milnacipran—Erythema multiforme—Simvastatin—atherosclerosis	0.0042	0.0042	CcSEcCtD
Milnacipran—Mediastinal disorder—Ezetimibe—atherosclerosis	0.0042	0.0042	CcSEcCtD
Milnacipran—Flushing—Simvastatin—atherosclerosis	0.00412	0.00412	CcSEcCtD
Milnacipran—Mental disorder—Ezetimibe—atherosclerosis	0.00408	0.00408	CcSEcCtD
Milnacipran—Hepatitis—Niacin—atherosclerosis	0.00408	0.00408	CcSEcCtD
Milnacipran—Flatulence—Lovastatin—atherosclerosis	0.00407	0.00407	CcSEcCtD
Milnacipran—Hypoaesthesia—Niacin—atherosclerosis	0.00406	0.00406	CcSEcCtD
Milnacipran—Malnutrition—Ezetimibe—atherosclerosis	0.00406	0.00406	CcSEcCtD
Milnacipran—Dysgeusia—Lovastatin—atherosclerosis	0.00405	0.00405	CcSEcCtD
Milnacipran—Oedema peripheral—Niacin—atherosclerosis	0.00402	0.00402	CcSEcCtD
Milnacipran—Hepatitis—Pravastatin—atherosclerosis	0.00402	0.00402	CcSEcCtD
Milnacipran—Hypoaesthesia—Pravastatin—atherosclerosis	0.004	0.004	CcSEcCtD
Milnacipran—Flatulence—Ezetimibe—atherosclerosis	0.004	0.004	CcSEcCtD
Milnacipran—Chills—Simvastatin—atherosclerosis	0.00399	0.00399	CcSEcCtD
Milnacipran—Infection—Rosuvastatin—atherosclerosis	0.00396	0.00396	CcSEcCtD
Milnacipran—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00391	0.00391	CcSEcCtD
Milnacipran—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.0039	0.0039	CcSEcCtD
Milnacipran—Vision blurred—Lovastatin—atherosclerosis	0.0039	0.0039	CcSEcCtD
Milnacipran—Mental disorder—Simvastatin—atherosclerosis	0.00389	0.00389	CcSEcCtD
Milnacipran—Tremor—Lovastatin—atherosclerosis	0.00387	0.00387	CcSEcCtD
Milnacipran—Eye disorder—Niacin—atherosclerosis	0.00381	0.00381	CcSEcCtD
Milnacipran—Flatulence—Simvastatin—atherosclerosis	0.00381	0.00381	CcSEcCtD
Milnacipran—Erythema multiforme—Pravastatin—atherosclerosis	0.0038	0.0038	CcSEcCtD
Milnacipran—Dysgeusia—Simvastatin—atherosclerosis	0.00379	0.00379	CcSEcCtD
Milnacipran—Flushing—Niacin—atherosclerosis	0.00379	0.00379	CcSEcCtD
Milnacipran—Flushing—Pravastatin—atherosclerosis	0.00373	0.00373	CcSEcCtD
Milnacipran—Cardiac disorder—Pravastatin—atherosclerosis	0.00373	0.00373	CcSEcCtD
Milnacipran—Angiopathy—Niacin—atherosclerosis	0.0037	0.0037	CcSEcCtD
Milnacipran—Leukopenia—Lovastatin—atherosclerosis	0.0037	0.0037	CcSEcCtD
Milnacipran—Chills—Niacin—atherosclerosis	0.00366	0.00366	CcSEcCtD
Milnacipran—Vision blurred—Simvastatin—atherosclerosis	0.00365	0.00365	CcSEcCtD
Milnacipran—Tremor—Simvastatin—atherosclerosis	0.00362	0.00362	CcSEcCtD
Milnacipran—Chills—Pravastatin—atherosclerosis	0.0036	0.0036	CcSEcCtD
Milnacipran—Insomnia—Rosuvastatin—atherosclerosis	0.0036	0.0036	CcSEcCtD
Milnacipran—Palpitations—Ezetimibe—atherosclerosis	0.00358	0.00358	CcSEcCtD
Milnacipran—Paraesthesia—Rosuvastatin—atherosclerosis	0.00358	0.00358	CcSEcCtD
Milnacipran—Malnutrition—Niacin—atherosclerosis	0.00355	0.00355	CcSEcCtD
Milnacipran—Chest pain—Lovastatin—atherosclerosis	0.00352	0.00352	CcSEcCtD
Milnacipran—Anxiety—Lovastatin—atherosclerosis	0.00351	0.00351	CcSEcCtD
Milnacipran—Dyspepsia—Rosuvastatin—atherosclerosis	0.00351	0.00351	CcSEcCtD
Milnacipran—Hypertension—Ezetimibe—atherosclerosis	0.0035	0.0035	CcSEcCtD
Milnacipran—Flatulence—Niacin—atherosclerosis	0.0035	0.0035	CcSEcCtD
Milnacipran—Tension—Niacin—atherosclerosis	0.00349	0.00349	CcSEcCtD
Milnacipran—Leukopenia—Simvastatin—atherosclerosis	0.00346	0.00346	CcSEcCtD
Milnacipran—Chest pain—Ezetimibe—atherosclerosis	0.00345	0.00345	CcSEcCtD
Milnacipran—Flatulence—Pravastatin—atherosclerosis	0.00345	0.00345	CcSEcCtD
Milnacipran—Dry mouth—Lovastatin—atherosclerosis	0.00344	0.00344	CcSEcCtD
Milnacipran—Tension—Pravastatin—atherosclerosis	0.00343	0.00343	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00343	0.00343	CcSEcCtD
Milnacipran—Dysgeusia—Pravastatin—atherosclerosis	0.00342	0.00342	CcSEcCtD
Milnacipran—Constipation—Rosuvastatin—atherosclerosis	0.00341	0.00341	CcSEcCtD
Milnacipran—Dry mouth—Ezetimibe—atherosclerosis	0.00338	0.00338	CcSEcCtD
Milnacipran—Infection—Lovastatin—atherosclerosis	0.00335	0.00335	CcSEcCtD
Milnacipran—Vision blurred—Niacin—atherosclerosis	0.00335	0.00335	CcSEcCtD
Milnacipran—Thrombocytopenia—Lovastatin—atherosclerosis	0.0033	0.0033	CcSEcCtD
Milnacipran—Vision blurred—Pravastatin—atherosclerosis	0.0033	0.0033	CcSEcCtD
Milnacipran—Chest pain—Simvastatin—atherosclerosis	0.00329	0.00329	CcSEcCtD
Milnacipran—Infection—Ezetimibe—atherosclerosis	0.00329	0.00329	CcSEcCtD
Milnacipran—Anxiety—Simvastatin—atherosclerosis	0.00328	0.00328	CcSEcCtD
Milnacipran—Tremor—Pravastatin—atherosclerosis	0.00328	0.00328	CcSEcCtD
Milnacipran—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00326	0.00326	CcSEcCtD
Milnacipran—Nervous system disorder—Ezetimibe—atherosclerosis	0.00325	0.00325	CcSEcCtD
Milnacipran—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00324	0.00324	CcSEcCtD
Milnacipran—Anorexia—Lovastatin—atherosclerosis	0.00322	0.00322	CcSEcCtD
Milnacipran—Skin disorder—Ezetimibe—atherosclerosis	0.00322	0.00322	CcSEcCtD
Milnacipran—Syncope—Niacin—atherosclerosis	0.00319	0.00319	CcSEcCtD
Milnacipran—Leukopenia—Niacin—atherosclerosis	0.00318	0.00318	CcSEcCtD
Milnacipran—Urticaria—Rosuvastatin—atherosclerosis	0.00316	0.00316	CcSEcCtD
Milnacipran—Abdominal pain—Rosuvastatin—atherosclerosis	0.00315	0.00315	CcSEcCtD
Milnacipran—Palpitations—Niacin—atherosclerosis	0.00314	0.00314	CcSEcCtD
Milnacipran—Infection—Simvastatin—atherosclerosis	0.00314	0.00314	CcSEcCtD
Milnacipran—Leukopenia—Pravastatin—atherosclerosis	0.00313	0.00313	CcSEcCtD
Milnacipran—Loss of consciousness—Niacin—atherosclerosis	0.00312	0.00312	CcSEcCtD
Milnacipran—Thrombocytopenia—Simvastatin—atherosclerosis	0.00309	0.00309	CcSEcCtD
Milnacipran—Insomnia—Lovastatin—atherosclerosis	0.00305	0.00305	CcSEcCtD
Milnacipran—Paraesthesia—Lovastatin—atherosclerosis	0.00303	0.00303	CcSEcCtD
Milnacipran—Hypertension—Pravastatin—atherosclerosis	0.00302	0.00302	CcSEcCtD
Milnacipran—Anorexia—Simvastatin—atherosclerosis	0.00301	0.00301	CcSEcCtD
Milnacipran—Dyspnoea—Lovastatin—atherosclerosis	0.00301	0.00301	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.003	0.003	CcSEcCtD
Milnacipran—Insomnia—Ezetimibe—atherosclerosis	0.00299	0.00299	CcSEcCtD
Milnacipran—Chest pain—Pravastatin—atherosclerosis	0.00298	0.00298	CcSEcCtD
Milnacipran—Paraesthesia—Ezetimibe—atherosclerosis	0.00297	0.00297	CcSEcCtD
Milnacipran—Dyspepsia—Lovastatin—atherosclerosis	0.00297	0.00297	CcSEcCtD
Milnacipran—Anxiety—Pravastatin—atherosclerosis	0.00297	0.00297	CcSEcCtD
Milnacipran—Dry mouth—Niacin—atherosclerosis	0.00296	0.00296	CcSEcCtD
Milnacipran—Dyspnoea—Ezetimibe—atherosclerosis	0.00295	0.00295	CcSEcCtD
Milnacipran—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00293	0.00293	CcSEcCtD
Milnacipran—Decreased appetite—Lovastatin—atherosclerosis	0.00293	0.00293	CcSEcCtD
Milnacipran—Dyspepsia—Ezetimibe—atherosclerosis	0.00291	0.00291	CcSEcCtD
Milnacipran—Fatigue—Lovastatin—atherosclerosis	0.00291	0.00291	CcSEcCtD
Milnacipran—Constipation—Lovastatin—atherosclerosis	0.00289	0.00289	CcSEcCtD
Milnacipran—Decreased appetite—Ezetimibe—atherosclerosis	0.00288	0.00288	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00286	0.00286	CcSEcCtD
Milnacipran—Asthenia—Rosuvastatin—atherosclerosis	0.00286	0.00286	CcSEcCtD
Milnacipran—Insomnia—Simvastatin—atherosclerosis	0.00286	0.00286	CcSEcCtD
Milnacipran—Fatigue—Ezetimibe—atherosclerosis	0.00285	0.00285	CcSEcCtD
Milnacipran—Shock—Niacin—atherosclerosis	0.00285	0.00285	CcSEcCtD
Milnacipran—Infection—Pravastatin—atherosclerosis	0.00284	0.00284	CcSEcCtD
Milnacipran—Paraesthesia—Simvastatin—atherosclerosis	0.00283	0.00283	CcSEcCtD
Milnacipran—Constipation—Ezetimibe—atherosclerosis	0.00283	0.00283	CcSEcCtD
Milnacipran—Tachycardia—Niacin—atherosclerosis	0.00283	0.00283	CcSEcCtD
Milnacipran—Pruritus—Rosuvastatin—atherosclerosis	0.00282	0.00282	CcSEcCtD
Milnacipran—Skin disorder—Niacin—atherosclerosis	0.00282	0.00282	CcSEcCtD
Milnacipran—Dyspnoea—Simvastatin—atherosclerosis	0.00281	0.00281	CcSEcCtD
Milnacipran—Hyperhidrosis—Niacin—atherosclerosis	0.0028	0.0028	CcSEcCtD
Milnacipran—Thrombocytopenia—Pravastatin—atherosclerosis	0.00279	0.00279	CcSEcCtD
Milnacipran—Dyspepsia—Simvastatin—atherosclerosis	0.00278	0.00278	CcSEcCtD
Milnacipran—Anorexia—Niacin—atherosclerosis	0.00276	0.00276	CcSEcCtD
Milnacipran—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00276	0.00276	CcSEcCtD
Milnacipran—Hyperhidrosis—Pravastatin—atherosclerosis	0.00276	0.00276	CcSEcCtD
Milnacipran—Decreased appetite—Simvastatin—atherosclerosis	0.00274	0.00274	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00273	0.00273	CcSEcCtD
Milnacipran—Diarrhoea—Rosuvastatin—atherosclerosis	0.00272	0.00272	CcSEcCtD
Milnacipran—Fatigue—Simvastatin—atherosclerosis	0.00272	0.00272	CcSEcCtD
Milnacipran—Anorexia—Pravastatin—atherosclerosis	0.00272	0.00272	CcSEcCtD
Milnacipran—Hypotension—Niacin—atherosclerosis	0.00271	0.00271	CcSEcCtD
Milnacipran—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00271	0.00271	CcSEcCtD
Milnacipran—Constipation—Simvastatin—atherosclerosis	0.0027	0.0027	CcSEcCtD
Milnacipran—Urticaria—Lovastatin—atherosclerosis	0.00268	0.00268	CcSEcCtD
Milnacipran—Body temperature increased—Lovastatin—atherosclerosis	0.00267	0.00267	CcSEcCtD
Milnacipran—Abdominal pain—Lovastatin—atherosclerosis	0.00267	0.00267	CcSEcCtD
Milnacipran—Dizziness—Rosuvastatin—atherosclerosis	0.00263	0.00263	CcSEcCtD
Milnacipran—Urticaria—Ezetimibe—atherosclerosis	0.00263	0.00263	CcSEcCtD
Milnacipran—Insomnia—Niacin—atherosclerosis	0.00262	0.00262	CcSEcCtD
Milnacipran—Abdominal pain—Ezetimibe—atherosclerosis	0.00262	0.00262	CcSEcCtD
Milnacipran—Body temperature increased—Ezetimibe—atherosclerosis	0.00262	0.00262	CcSEcCtD
Milnacipran—Paraesthesia—Niacin—atherosclerosis	0.0026	0.0026	CcSEcCtD
Milnacipran—Dyspnoea—Niacin—atherosclerosis	0.00258	0.00258	CcSEcCtD
Milnacipran—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00258	0.00258	CcSEcCtD
Milnacipran—Insomnia—Pravastatin—atherosclerosis	0.00258	0.00258	CcSEcCtD
Milnacipran—Somnolence—Niacin—atherosclerosis	0.00258	0.00258	CcSEcCtD
Milnacipran—Paraesthesia—Pravastatin—atherosclerosis	0.00256	0.00256	CcSEcCtD
Milnacipran—Dyspepsia—Niacin—atherosclerosis	0.00255	0.00255	CcSEcCtD
Milnacipran—Dyspnoea—Pravastatin—atherosclerosis	0.00254	0.00254	CcSEcCtD
Milnacipran—Decreased appetite—Niacin—atherosclerosis	0.00252	0.00252	CcSEcCtD
Milnacipran—Dyspepsia—Pravastatin—atherosclerosis	0.00251	0.00251	CcSEcCtD
Milnacipran—Rash—Rosuvastatin—atherosclerosis	0.00251	0.00251	CcSEcCtD
Milnacipran—Dermatitis—Rosuvastatin—atherosclerosis	0.00251	0.00251	CcSEcCtD
Milnacipran—Urticaria—Simvastatin—atherosclerosis	0.00251	0.00251	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Niacin—atherosclerosis	0.0025	0.0025	CcSEcCtD
Milnacipran—Body temperature increased—Simvastatin—atherosclerosis	0.0025	0.0025	CcSEcCtD
Milnacipran—Abdominal pain—Simvastatin—atherosclerosis	0.0025	0.0025	CcSEcCtD
Milnacipran—Headache—Rosuvastatin—atherosclerosis	0.00249	0.00249	CcSEcCtD
Milnacipran—Hypersensitivity—Lovastatin—atherosclerosis	0.00249	0.00249	CcSEcCtD
Milnacipran—Decreased appetite—Pravastatin—atherosclerosis	0.00248	0.00248	CcSEcCtD
Milnacipran—Fatigue—Pravastatin—atherosclerosis	0.00246	0.00246	CcSEcCtD
Milnacipran—Constipation—Pravastatin—atherosclerosis	0.00244	0.00244	CcSEcCtD
Milnacipran—Hypersensitivity—Ezetimibe—atherosclerosis	0.00244	0.00244	CcSEcCtD
Milnacipran—Asthenia—Lovastatin—atherosclerosis	0.00242	0.00242	CcSEcCtD
Milnacipran—Pruritus—Lovastatin—atherosclerosis	0.00239	0.00239	CcSEcCtD
Milnacipran—Asthenia—Ezetimibe—atherosclerosis	0.00238	0.00238	CcSEcCtD
Milnacipran—Gastrointestinal pain—Niacin—atherosclerosis	0.00237	0.00237	CcSEcCtD
Milnacipran—Nausea—Rosuvastatin—atherosclerosis	0.00237	0.00237	CcSEcCtD
Milnacipran—Pruritus—Ezetimibe—atherosclerosis	0.00234	0.00234	CcSEcCtD
Milnacipran—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00233	0.00233	CcSEcCtD
Milnacipran—Hypersensitivity—Simvastatin—atherosclerosis	0.00233	0.00233	CcSEcCtD
Milnacipran—Diarrhoea—Lovastatin—atherosclerosis	0.00231	0.00231	CcSEcCtD
Milnacipran—Urticaria—Niacin—atherosclerosis	0.0023	0.0023	CcSEcCtD
Milnacipran—Abdominal pain—Niacin—atherosclerosis	0.00229	0.00229	CcSEcCtD
Milnacipran—Body temperature increased—Niacin—atherosclerosis	0.00229	0.00229	CcSEcCtD
Milnacipran—Urticaria—Pravastatin—atherosclerosis	0.00227	0.00227	CcSEcCtD
Milnacipran—Asthenia—Simvastatin—atherosclerosis	0.00227	0.00227	CcSEcCtD
Milnacipran—Diarrhoea—Ezetimibe—atherosclerosis	0.00226	0.00226	CcSEcCtD
Milnacipran—Abdominal pain—Pravastatin—atherosclerosis	0.00226	0.00226	CcSEcCtD
Milnacipran—Body temperature increased—Pravastatin—atherosclerosis	0.00226	0.00226	CcSEcCtD
Milnacipran—Pruritus—Simvastatin—atherosclerosis	0.00223	0.00223	CcSEcCtD
Milnacipran—Dizziness—Lovastatin—atherosclerosis	0.00223	0.00223	CcSEcCtD
Milnacipran—Dizziness—Ezetimibe—atherosclerosis	0.00219	0.00219	CcSEcCtD
Milnacipran—Diarrhoea—Simvastatin—atherosclerosis	0.00216	0.00216	CcSEcCtD
Milnacipran—Vomiting—Lovastatin—atherosclerosis	0.00215	0.00215	CcSEcCtD
Milnacipran—Hypersensitivity—Niacin—atherosclerosis	0.00214	0.00214	CcSEcCtD
Milnacipran—Rash—Lovastatin—atherosclerosis	0.00213	0.00213	CcSEcCtD
Milnacipran—Dermatitis—Lovastatin—atherosclerosis	0.00213	0.00213	CcSEcCtD
Milnacipran—Headache—Lovastatin—atherosclerosis	0.00211	0.00211	CcSEcCtD
Milnacipran—Vomiting—Ezetimibe—atherosclerosis	0.0021	0.0021	CcSEcCtD
Milnacipran—Hypersensitivity—Pravastatin—atherosclerosis	0.0021	0.0021	CcSEcCtD
Milnacipran—Dizziness—Simvastatin—atherosclerosis	0.00209	0.00209	CcSEcCtD
Milnacipran—Rash—Ezetimibe—atherosclerosis	0.00209	0.00209	CcSEcCtD
Milnacipran—Dermatitis—Ezetimibe—atherosclerosis	0.00209	0.00209	CcSEcCtD
Milnacipran—Asthenia—Niacin—atherosclerosis	0.00208	0.00208	CcSEcCtD
Milnacipran—Headache—Ezetimibe—atherosclerosis	0.00207	0.00207	CcSEcCtD
Milnacipran—Pruritus—Niacin—atherosclerosis	0.00205	0.00205	CcSEcCtD
Milnacipran—Asthenia—Pravastatin—atherosclerosis	0.00205	0.00205	CcSEcCtD
Milnacipran—Pruritus—Pravastatin—atherosclerosis	0.00202	0.00202	CcSEcCtD
Milnacipran—Vomiting—Simvastatin—atherosclerosis	0.00201	0.00201	CcSEcCtD
Milnacipran—Nausea—Lovastatin—atherosclerosis	0.002	0.002	CcSEcCtD
Milnacipran—Rash—Simvastatin—atherosclerosis	0.00199	0.00199	CcSEcCtD
Milnacipran—Dermatitis—Simvastatin—atherosclerosis	0.00199	0.00199	CcSEcCtD
Milnacipran—Diarrhoea—Niacin—atherosclerosis	0.00198	0.00198	CcSEcCtD
Milnacipran—Headache—Simvastatin—atherosclerosis	0.00198	0.00198	CcSEcCtD
Milnacipran—Nausea—Ezetimibe—atherosclerosis	0.00197	0.00197	CcSEcCtD
Milnacipran—Diarrhoea—Pravastatin—atherosclerosis	0.00195	0.00195	CcSEcCtD
Milnacipran—Dizziness—Niacin—atherosclerosis	0.00192	0.00192	CcSEcCtD
Milnacipran—Dizziness—Pravastatin—atherosclerosis	0.00189	0.00189	CcSEcCtD
Milnacipran—Nausea—Simvastatin—atherosclerosis	0.00188	0.00188	CcSEcCtD
Milnacipran—Vomiting—Niacin—atherosclerosis	0.00184	0.00184	CcSEcCtD
Milnacipran—Rash—Niacin—atherosclerosis	0.00183	0.00183	CcSEcCtD
Milnacipran—Dermatitis—Niacin—atherosclerosis	0.00183	0.00183	CcSEcCtD
Milnacipran—Headache—Niacin—atherosclerosis	0.00182	0.00182	CcSEcCtD
Milnacipran—Vomiting—Pravastatin—atherosclerosis	0.00181	0.00181	CcSEcCtD
Milnacipran—Rash—Pravastatin—atherosclerosis	0.0018	0.0018	CcSEcCtD
Milnacipran—Dermatitis—Pravastatin—atherosclerosis	0.0018	0.0018	CcSEcCtD
Milnacipran—Headache—Pravastatin—atherosclerosis	0.00179	0.00179	CcSEcCtD
Milnacipran—Nausea—Niacin—atherosclerosis	0.00172	0.00172	CcSEcCtD
Milnacipran—Nausea—Pravastatin—atherosclerosis	0.0017	0.0017	CcSEcCtD
